Riskpilot← Back to searchSign inGet full accessÅRDAL BIO AS
ASActiveOrg 994723995Svadberg, 4137 Årdal I RyfylkeProduction of electricity from renewable sources · NACE 3512Est. 20090 employees
Revenue 2024
NOK 0
EBITDA margin
—
-249% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -22K
-280% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -23K | -249% |
| Net profit | NOK -22K | -280% |
| Total assets | NOK 30K | -42% |
| Equity | NOK 30K | -42% |
| Employees | 0 | — |
Legal name
ÅRDAL BIO AS
Org number
994723995
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
3. november 2009
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Produksjon av bioenergi samt hva som herved står i forbindelse, herunder deltakelse i andre selskaper med lignende formål.
Address
Svadberg, 4137 Årdal I Ryfylke
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −9 | −8 | −36 | −7 | −23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −9 | −8 | −36 | −7 | −23 |
| Net financials | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | −8 | −8 | −35 | −6 | −22 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −8 | −8 | −35 | −6 | −22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 110 | 93 | 58 | 52 | 30 |
| Equity | 101 | 93 | 58 | 52 | 30 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 | 0 | 0 | 0 | 0 |
| Total debt | 9 | 0 | 0 | 0 | 0 |
EBITDA margin
-2314700.0%
This company
15.8%
Market median
-14650100% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-73.7%
This company
18.4%
Market median
-501% vs market
20202024
Net profit margin
-2200400.0%
This company
8.1%
Market median
-27165532% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2022 | |
| Individual | 18.75% | 18.75% | 2022 | |
| Individual | 12.5% | 12.5% | 2022 | |
| Company | 12.5% | 12.5% | 2022 | |
| Company | 12.5% | 12.5% | 2022 | |
| Individual | 12.5% | 12.5% | 2022 | |
| Individual | 6.25% | 6.25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ÅRDAL BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Arne Sie | Chairman | 0 companies |
| Aleksander Sie | Chairman | 0 companies |
| Kjell Inge Mæland | Board of Directors | 0 companies |